Back to top
Rydex Biotechnology Fund - C Class: (MF: RYCFX)
(NASDAQ Mutual Funds) As of Jan 30, 2026 05:30 PM ET
$43.97 USD
-0.40 (-0.90%)
Zacks MF Rank
4-Sell of 5 4
Latest Performance as of Dec 31, 2025
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | 29.44 | 18 |
| 3 months | 14.95 | 40 |
| 6 months | 32.04 | 17 |
| 1 Year | 29.44 | 18 |
| 3 Year | 10.14 | 35 |
| 5 Year | 3.00 | 83 |
| 10 Year | 4.81 | 97 |
* Annual for three years and beyond.
| Bull Market (9/02 - 10/07) | 83.46 |
| Bear Market (10/07 - 2/09) | -27.34 |
| Bull Market (2/09 - 3/21) | 657.53 |
Load Adjusted Returns as of Dec 31, 2025
| 1 Year | 28.14 |
| 5 Year | 2.99 |
| 10 Year | 4.80 |
| Since Inception | 7.40 |
Quarterly Return
| 1st Qtr. | 2nd Qtr. | 3rd Qtr. | 4th Qtr. | |
|---|---|---|---|---|
| 2025 | -1.60 | -0.37 | 14.87 | 14.95 |
| 2024 | 0.55 | 1.83 | 4.64 | -8.27 |
| 2023 | -2.43 | -0.14 | -4.07 | 12.37 |
| 2022 | -10.10 | -10.45 | -2.40 | 9.56 |
| 2021 | -1.78 | 9.80 | -3.41 | -3.22 |
Annual Return
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| % Total Return | 29.44 | -1.71 | 5.01 | -13.92 | 0.80 | 20.86 | 23.77 | -9.89 | 28.45 | -20.30 |
| % Total Return Rel to Index | 11.22 | -26.74 | -21.23 | 4.27 | -27.88 | 2.46 | -7.71 | -5.49 | 6.65 | -32.23 |
| % Total Return Rel to Peer | 8.78 | -4.33 | -0.75 | -4.51 | -7.88 | -0.41 | -2.90 | -10.01 | 6.33 | -9.52 |
| % Perf Quintile vs Peer* | 0.00 | 0.00 | 3.00 | 5.00 | 5.00 | 3.00 | 4.00 | 5.00 | 2.00 | 5.00 |
| % Dividends | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| % Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Gains ($) | 9.41 | 9.42 | 0.00 | 0.90 | 15.77 | 6.95 | 3.60 | 9.88 | 4.70 | 0.00 |
| Expense Ratio | 2.40 | 2.40 | 2.39 | 2.36 | 2.45 | 2.48 | 2.46 | 2.37 | 2.36 | 2.33 |
* 1 = Top 20%, 5 = Bottom 20%